Company Search:
Advanced Search
Sponsored Links
ImmuCell Corporation Company Snapshot
ImmuCell Corporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares ImmuCell with three other companies in this sector in the United States: Achieve Life Sciences Inc (2016 sales of $5.06 million of which 100% was Cancer Therapies), Celldex Therapeutics, Incorporation ($6.79 million of which 100% was Health Care Products), and Immunomedics, Inc. ($3.23 million of which 100% was Biopharma Products).

Sales Analysis. During the year ended December of 2016, sales at ImmuCell were $9.54 million. This is a decrease of 6.7% versus 2015, when the company's sales were $10.23 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ImmuCell Corporation
  Stock Performance Chart for ImmuCell Corporation
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 7.71
(Figures in U.S. Dollars)
1 Week -1.9%   13 Weeks -11.9%  
4 Weeks 4.3%   52 Weeks 27.4%  
ImmuCell Corporation Key Data:
  Ticker: ICCC Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 9,543,961
(Year Ending Jan 2017).
Employees: 29
  Currency: U.S. Dollars Market Cap: 38,946,217
  Fiscal Yr Ends: December Shares Outstanding: 5,051,390
  Share Type: Common Closely Held Shares: 1,587,592
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.